CSPC Pharmaceutical Group Ltd (1093.HK)
Company Info
Highlights
HK$57.69B
HK$0.45
10.64
12.21
HK$16.60B
HK$11.82B
HK$4.42B
HK$4.33 - HK$7.62
HK$7.35
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of HK$10,000 in CSPC Pharmaceutical Group Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
CSPC Pharmaceutical Group Ltd had a return of -27.79% year-to-date (YTD) and -20.93% in the last 12 months. Over the past 10 years, CSPC Pharmaceutical Group Ltd had an annualized return of -1.35%, while the S&P 500 had an annualized return of 11.62%, indicating that CSPC Pharmaceutical Group Ltd did not perform as well as the benchmark.
1093.HK
-27.79%
-6.54%
-26.85%
-20.93%
-19.94%
-1.35%
^GSPC (Benchmark)
27.68%
1.58%
13.90%
32.27%
14.27%
11.62%
Monthly Returns
The table below presents the monthly returns of 1093.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -20.94% | 6.62% | 0.49% | 5.37% | 4.46% | -6.18% | -6.43% | -17.18% | 25.52% | -2.40% | -11.83% | -27.79% | |
| 2023 | 9.02% | -5.71% | -8.42% | 3.37% | -14.54% | 1.49% | -4.70% | -9.09% | -0.32% | 18.99% | 3.22% | 2.98% | -7.80% |
| 2022 | 11.57% | -2.12% | -2.16% | -10.50% | 5.02% | -7.26% | 10.27% | -6.99% | -1.38% | 3.73% | 23.79% | -17.92% | -0.70% |
| 2021 | -0.13% | 2.27% | 16.05% | 2.34% | 27.64% | -7.72% | -6.76% | -5.82% | -4.58% | -12.85% | -0.74% | 4.83% | 8.57% |
| 2020 | -6.89% | 2.66% | -12.61% | -0.77% | -1.43% | -2.80% | 11.07% | 5.90% | -12.68% | -45.53% | -7.34% | 4.76% | -56.88% |
| 2019 | 19.12% | -0.45% | 8.96% | 3.56% | -15.81% | -0.32% | 9.21% | 13.95% | 0.38% | 28.02% | -11.56% | 4.27% | 65.60% |
| 2018 | 10.01% | 4.15% | 15.32% | -3.12% | 21.92% | -3.46% | -13.50% | -3.41% | -16.06% | -0.48% | -4.23% | -28.66% | -28.16% |
| 2017 | 5.80% | 8.45% | 7.16% | 6.09% | 8.54% | -2.23% | 6.84% | 0.33% | 7.04% | 3.67% | 14.31% | 1.81% | 91.61% |
| 2016 | -17.42% | -5.35% | 13.41% | -1.57% | 2.46% | -1.74% | -2.75% | 12.22% | 3.05% | 3.61% | 3.61% | -0.60% | 5.40% |
| 2015 | -4.24% | -3.21% | 3.47% | 22.87% | -0.35% | -4.01% | -7.31% | 0.00% | -4.37% | 6.63% | 0.69% | 8.64% | 16.54% |
| 2014 | 5.07% | 8.86% | -1.86% | -6.11% | -4.67% | 1.31% | -2.58% | 7.46% | -0.77% | 11.04% | -3.36% | -0.87% | 12.48% |
| 2013 | 30.05% | 7.59% | 5.77% | 13.33% | 9.48% | -3.96% | 5.15% | -0.73% | 2.22% | 16.67% | 4.35% | 21.43% | 178.16% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of 1093.HK is 14, indicating that it is in the bottom 14% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for CSPC Pharmaceutical Group Ltd (1093.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
CSPC Pharmaceutical Group Ltd provided a 6.00% dividend yield over the last twelve months, with an annual payout of HK$0.30 per share. The company has been increasing its dividends for 9 consecutive years.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | HK$0.30 | HK$0.25 | HK$0.20 | HK$0.17 | HK$0.16 | HK$0.09 | HK$0.08 | HK$0.06 | HK$0.06 | HK$0.05 | HK$0.04 | HK$0.05 |
Dividend yield | 6.00% | 3.44% | 2.44% | 2.01% | 2.05% | 0.50% | 0.69% | 0.40% | 0.69% | 0.66% | 0.61% | 0.85% |
Monthly Dividends
The table displays the monthly dividend distributions for CSPC Pharmaceutical Group Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.14 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.16 | HK$0.00 | HK$0.00 | HK$0.30 |
| 2023 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.11 | HK$0.00 | HK$0.00 | HK$0.14 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.25 |
| 2022 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.10 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.10 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.20 |
| 2021 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.09 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.08 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.17 |
| 2020 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.13 | HK$0.00 | HK$0.00 | HK$0.04 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.16 |
| 2019 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.09 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.09 |
| 2018 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.08 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.08 |
| 2017 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.06 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.06 |
| 2016 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.06 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.06 |
| 2015 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.05 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.05 |
| 2014 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.04 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.04 |
| 2013 | HK$0.05 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.05 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the CSPC Pharmaceutical Group Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the CSPC Pharmaceutical Group Ltd was 80.26%, occurring on Sep 11, 2024. The portfolio has not yet recovered.
The current CSPC Pharmaceutical Group Ltd drawdown is 77.72%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -80.26% | Jun 6, 2018 | 1544 | Sep 11, 2024 | — | — | — |
| -78.03% | Apr 28, 2010 | 522 | Jun 5, 2012 | 386 | Dec 30, 2013 | 908 |
| -74.31% | Jun 20, 2003 | 738 | Jun 13, 2006 | 235 | May 25, 2007 | 973 |
| -72.98% | Oct 4, 2007 | 260 | Oct 27, 2008 | 213 | Sep 4, 2009 | 473 |
| -72.06% | Sep 14, 1999 | 495 | Sep 18, 2001 | 331 | Jan 22, 2003 | 826 |
Volatility
Volatility Chart
The current CSPC Pharmaceutical Group Ltd volatility is 5.74%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of CSPC Pharmaceutical Group Ltd compared to its peers in the Drug Manufacturers - General industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for 1093.HK in comparison to other companies of the Drug Manufacturers - General industry. Currently, 1093.HK has a PE value of 10.6. This PE value is considered to be low compared to the rest of the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for 1093.HK in comparison to other companies of the Drug Manufacturers - General industry. Currently, 1093.HK has a PEG value of 12.2. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for CSPC Pharmaceutical Group Ltd.
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |